Saturday, January 17, 2026
HomeNews

News

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, ...

CHA Hollywood Presbyterian Medical Center Appoints Jamie Yoo as CEO

CHA Hollywood Presbyterian Medical Center, a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, is pleased...

Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies

Cerner Enviza, an Oracle company, along with John Snow Labs, are now helping support the U.S. Food and Drug Administration's drug safety Sentinel Initiative. By developing artificial...

Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score, Thyroid Eye Disease

Horizon Therapeutics plc announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of...

Lightbeam Health Solutions Announces Platform Migration to Microsoft Azure SQL Database

Lightbeam Health Solutions, a leader in population health enablement solutions and services, announces its adoption of Microsoft Azure SQL Database to further accelerate the...
0FansLike
0FollowersFollow
spot_img

Hot Topics